BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26987104)

  • 1. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance.
    Mazzawi T; El-Salhy M
    Int J Mol Med; 2016 May; 37(5):1247-53. PubMed ID: 26987104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance.
    Mazzawi T; El-Salhy M
    Exp Biol Med (Maywood); 2017 Jul; 242(13):1355-1362. PubMed ID: 28737477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Gilja OH
    BMC Gastroenterol; 2017 Aug; 17(1):90. PubMed ID: 28764761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome.
    El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
    Scand J Gastroenterol; 2017; 52(6-7):691-697. PubMed ID: 28346031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome.
    El-Salhy M; Wendelbo IH; Gundersen D
    Mol Med Rep; 2013 Apr; 7(4):1241-4. PubMed ID: 23426642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome.
    Mazzawi T; Hausken T; Gundersen D; El-Salhy M
    Eur J Clin Nutr; 2016 Feb; 70(2):175-81. PubMed ID: 26603880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome.
    El-Salhy M; Lomholt-Beck B; Hausken T
    Scand J Gastroenterol; 2010 Dec; 45(12):1435-9. PubMed ID: 20602602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome.
    Mazzawi T; El-Salhy M
    Exp Ther Med; 2016 Sep; 12(3):1398-1404. PubMed ID: 27588061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance.
    Mazzawi T; Gundersen D; Hausken T; El-Salhy M
    Gastroenterol Res Pract; 2015; 2015():823897. PubMed ID: 25918524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.
    El-Salhy M; Hatlebakk JG; Hausken T
    World J Gastroenterol; 2015 Aug; 21(32):9577-87. PubMed ID: 26327765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome.
    El-Salhy M; Mazzawi T; Gundersen D; Hausken T
    Mol Med Rep; 2012 Dec; 6(6):1223-5. PubMed ID: 22992886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome.
    Mazzawi T; Gundersen D; Hausken T; El-Salhy M
    Mol Med Rep; 2014 Nov; 10(5):2322-6. PubMed ID: 25174455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Vaali K; Dizdar V; Hausken T
    Dig Dis Sci; 2010 Dec; 55(12):3508-13. PubMed ID: 20300845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome.
    Dlugosz A; Törnblom H; Mohammadian G; Morgan G; Veress B; Edvinsson B; Sandström G; Lindberg G
    BMC Gastroenterol; 2010 Feb; 10():19. PubMed ID: 20158890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine cells in the ileum of patients with irritable bowel syndrome.
    El-Salhy M; Gilja OH; Gundersen D; Hatlebakk JG; Hausken T
    World J Gastroenterol; 2014 Mar; 20(9):2383-91. PubMed ID: 24605036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Mazzawi T; El-Salhy M; Lied GA; Hausken T
    Front Cell Infect Microbiol; 2021; 11():524851. PubMed ID: 34055657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome.
    El-Salhy M; Gilja OH; Hausken T
    Mol Med Rep; 2014 Oct; 10(4):1753-7. PubMed ID: 25109259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome.
    El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
    Scand J Gastroenterol; 2017 Dec; 52(12):1331-1339. PubMed ID: 28853300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome.
    El-Salhy M; Gilja OH; Gundersen D; Hatlebakk JG; Hausken T
    Gastroenterol Res Pract; 2014; 2014():462856. PubMed ID: 25028588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal rectal endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Gundersen D; Hatlebakk JG; Gilja OH; Hausken T
    Regul Pept; 2014 Jan; 188():60-5. PubMed ID: 24316398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.